Diamonds and Dogs
10/10/14Exact Sciences Corporation (EXAS)
Exact Sciences is looking great today, up 35.76% to $24.60. The molecular diagnostics company saw its shares pop after Medicare officials recommended a $502 reimbursement for Exact Sciences colon cancer screening test. Colonguard is a non-invasive colon cancer screening test and was expected to see a reimbursement of $100-$500, so the news of $502 is above expectations. Shares of Exact Sciences climbed nearly $6.50 today and reached a new 52-week high of $26.79.
Procera Networks Inc. (PKT)
Procera Networks is seeing red today, down 33.33% to $5.70. The intelligent policy enforcement company saw its shares crash after releasing preliminary earnings. For the third quarter, management announced it expects revenue of $16 million which is a 25% decrease year over year. Furthermore, the company expects its full year revenue to be $70-75 million. Both numbers missed analysts' estimates $22.64 million and $85.16 million respectively. Shares of Procera fell to a new 52-week low of $5.61 intraday.